New Key Statistics Module, Z-Score and F-Score
NAS:ESPR Key Ratios
| Market Cap $ M | 413.02 |
| Enterprise Value $ M | 464.88 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 1.41 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 229.00 |
| EPS (TTM) $ | -0.99 |
| Beneish M-Score | 0.46 |
| 10-y EBITDA Growth Rate % | -0.40 |
| 5-y EBITDA Growth Rate % | 21.10 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -16.67 |
| EV-to-EBITDA | -16.72 |
| PEG | -- |
| Shares Outstanding M | 189.46 |
| Net Margin (%) | -37.65 |
| Operating Margin % | -15.10 |
| Pre-tax Margin (%) | -37.65 |
| Quick Ratio | 1.78 |
| Current Ratio | 2.22 |
| ROA % (ttm) | -33.62 |
| ROE % (ttm) | -- |
| ROIC % (ttm) | -105.26 |
| Dividend Yield % | -- |
| Altman Z-Score | -4.19 |
ESPR Number of Guru Trades
ESPR Volume of Guru Trades
Gurus Latest Trades with NAS:ESPR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ESPR is held by these investors
Total 1
Esperion Therapeutics Inc Insider Transactions
No Available Data
News about NAS:ESPR
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers